男性HPV疫苗接种安全性:基于VAERS的药物警戒研究
本研究回顾性分析2006年1月至2018年9月美国疫苗不良事件报告系统(VAERS)中男性HPV疫苗接种后的不良事件报告,共纳入5493份报告。采用报告比值比(ROR)进行数据挖掘,发现晕厥、意识丧失和跌倒的报告比例显著高于其他疫苗。结论认为男性对HPV疫苗总体耐受良好,但需考虑自发报告系统的局限性。
要点
- 男性HPV疫苗不良事件中晕厥报告比值比2.85(95%CI 1.41-5.76)。
- 意识丧失报告比值比2.79(95%CI 1.36-5.72),跌倒3.54(95%CI 2.00-6.26)。
- 多数不良事件已在上市前临床试验中报告,总体耐受性良好。
核心结论
- 男性接种HPV疫苗总体耐受良好,但晕厥等事件存在报告比例失衡。
研究设计与样本
- 回顾性药物警戒研究,分析2006年1月1日至2018年9月30日VAERS数据库中男性HPV疫苗不良事件报告,共5493份。
主要发现
- 晕厥报告701例,报告比值比2.85(95%CI 1.41-5.76)。
- 意识丧失报告425例,报告比值比2.79(95%CI 1.36-5.72)。
- 跌倒报告272例,报告比值比3.54(95%CI 2.00-6.26)。
临床怎么用
- 临床接种男性HPV疫苗时应关注晕厥及跌倒风险,建议接种后留观。
局限性
- 自发报告系统存在报告偏倚、漏报等固有局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Human papilloma virus (HPV) is 1 of the most common sexually transmitted infection responsible for different types of cancer: cervical, penile, vulvar, anal and oropharyngeal. It can affect both males and females. Our aim was to enrich the knowledge on the safety profiles of HPV vaccines in the male population. METHODS: We reviewed all the reports of adverse events following immunization (AEFI) present in the US Vaccine Adverse Event Reporting System from 1 January 2006 to 30 September 2018. Statistical data mining was performed using the reporting odds ratio with 95% confidence interval in order to detect disproportionality in reporting. RESULTS: A total of 5493 reports of AEFI were retrieved. The events most reported and that proportionally occurred more frequently with HPV vaccines than with others in males were: syncope (n = 701, reporting odds ratio = 2.85, 95% confidence interval [1.41-5.76p), loss of consciousness (n = 425, 2.79 [1.36-5.72]) and fall (n = 272, 3.54 [2.00-6.26]). CONCLUSION: Most of the AEFIs were already reported in premarketing clinical trials and acknowledged for the corresponding vaccines. A disproportionate reporting was found for some of these events including syncope. The HPV vaccines are generally well tolerated in males, although limitations own of spontaneous reporting should be considered.
引用
- Bonaldo G, Montanaro N, Vaccheri A, et al. Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System. Br J Clin Pharmacol. 2020. PMID: 33145777. doi:10.1111/bcp.14584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。